Imunon Inc (IMNN)
1.18
+0.05
(+4.42%)
USD |
NASDAQ |
Jun 28, 16:00
1.14
-0.04
(-3.39%)
After-Hours: 20:00
Imunon Net Income (Annual): -19.52M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.52M |
| December 31, 2022 | -35.90M |
| December 31, 2021 | -20.77M |
| December 31, 2020 | -21.48M |
| December 31, 2019 | -16.85M |
| December 31, 2018 | -11.88M |
| December 31, 2017 | -20.40M |
| December 31, 2016 | -22.05M |
| December 31, 2015 | -22.46M |
| December 31, 2014 | -25.49M |
| December 31, 2013 | -8.251M |
| December 31, 2012 | -26.57M |
| December 31, 2011 | -23.22M |
| December 31, 2010 | -18.82M |
| Date | Value |
|---|---|
| December 31, 2009 | -15.20M |
| December 31, 2008 | -11.79M |
| December 31, 2007 | 35.35M |
| December 31, 2006 | -7.584M |
| December 31, 2005 | -8.685M |
| December 31, 2004 | -13.98M |
| September 30, 2003 | -13.27M |
| September 30, 2002 | -9.751M |
| September 30, 2001 | -6.923M |
| September 30, 2000 | -4.547M |
| September 30, 1999 | -2.40M |
| September 30, 1998 | -4.200M |
| September 30, 1997 | -3.052M |
| September 30, 1996 | -1.934M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-35.90M
Minimum
2022
-16.85M
Maximum
2019
-22.90M
Average
-20.77M
Median
2021
Net Income (Annual) Benchmarks
| iBio Inc | -65.01M |
| Ocugen Inc | -63.08M |
| Avalo Therapeutics Inc | -31.54M |
| Petros Pharmaceuticals Inc | -8.163M |
| NovaBay Pharmaceuticals Inc | -9.64M |